Sergiu Groppa

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
No aliases are listed.
Publication record
238 papers · 5,143 citations · H-index 36

PAPERS

Imaging the hidden player: Choroid plexus enlargement in multiple sclerosis.
20260 citationsauthor #4
Choroid plexus enlargement associates with serum neurofilament and predicts relapse-free progression in multiple sclerosis.
20260 citationsauthor #17
Neurological Examinations of Patients Initially Diagnosed With Wild‐Type Transthyretin Amyloidosis (wtATTR)
20250 citationsauthor #10
Biomarker combinations from different modalities predict early disability accumulation in multiple sclerosis
20255 citationsauthor #9
Single-cell Spatial Transcriptomics Reveals Disease-specific Microenvironmental Niches in Neurodegeneration and COVID-19
20251 citationsauthor #13
Extending the ALPS index: Associating whole-brain patterns with glymphatic-related diffusion metrics in multiple sclerosis.
20250 citationsauthor #5
Accelerated symptom improvement in Parkinson’s disease via remote internet-based optimization of deep brain stimulation therapy: a randomized controlled multicenter trial
20253 citationsauthor #2
Extended coverage of human serum glycosphingolipidome by 4D-RP-LC TIMS-PASEF unravels association with Parkinson’s disease
20255 citationsauthor #6
MRI-Based Evidence of Regular Physical Activity's Impact on Brain Networks for Modifying Disease Courses in Parkinson Disease.
20250 citationsauthor #2
O126 LONG-TERM ANTISEIZURE EFFECTS OF EPICTRANIAL FOCAL CORTEX STIMULATION (FCS) USING THE EASEE SYSTEM IN PHARMACORESISTANT FOCAL EPILEPSY
20250 citationsauthor #11
Targeting pathological brain activity-related to neuroinflammation through scRNA-seq for new personalized therapies in Parkinson’s disease
20253 citationsauthor #5
Neuroimaging in advanced Parkinson’s disease: insights into pathophysiology, biomarkers, and personalized therapies
20250 citationsauthor #2
Alterations of fecal short-chain fatty acids solely in the course of multiple sclerosis: rethinking the gut–brain axis in the early stages of MS
20250 citationsauthor #5
Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody–Associated Disease
20251 citationsauthor #23
A generalized epilepsy network derived from brain abnormalities and deep brain stimulation
202514 citationsauthor #16
How many stroke survivors develop problematic spasticity requiring pharmacological therapy? An international (Europe and USA) observational study protocol
20251 citationsauthor #4
Therapeutic approaches in adults with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A review of current evidence.
20250 citationsauthor #7
Prognostic value of blood-based biomarkers in multiple sclerosis patients in the absence of clinical relapses or new MRI lesions
20250 citationsauthor #6
A cross-sectional multicentre study of multishell diffusion MRI in multiple sclerosis.
20250 citationsauthor #18
Quality of life and synergistic combinations of antiseizure medication in patients treated with cenobamate in early therapy lines for focal-onset seizures.
20251 citationsauthor #8
Two‐year outcomes of epicranial focal cortex stimulation in pharmacoresistant focal epilepsy
20257 citationsauthor #11
Quantifying neurodegeneration and vulnerable networks with the aid of structural covariance analysis from magnetic resonance imaging.
20250 citationsauthor #5
Structural covariance analysis for neurodegenerative and neuroinflammatory brain disorders
20257 citationsauthor #7
Role of the subthalamic nucleus in motor control.
20250 citationsauthor #3
Frequency- and layer-specific effects of high-frequency STN stimulation on mouse motor cortical areas in vivo.
20250 citationsauthor #6
The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population
20252 citationsauthor #76
Introduction of a smartwatch-based Parkinson's management in Germany: Health economic considerations from a payer perspective
20250 citationsauthor #5
prm-PASEF-Based Quantification and Isomeric Model for Extended Coverage of Human Plasma Lipidome in Parkinson’s Disease
20250 citationsauthor #6
Intravenous tenecteplase for basilar artery occlusion: a case report
20250 citationsauthor #5
Targeting the centromedian nucleus of the thalamus for epilepsy
20251 citationsauthor #8
ATP1A3 Variants, Variably Penetrant Short QT Intervals, and Lethal Ventricular Arrhythmias.
20254 citationsauthor #36
Conservation of structural brain connectivity in people with multiple sclerosis
20241 citationsauthor #6
Cenobamate as an Early Adjunctive Treatment in Drug-Resistant Focal-Onset Seizures: An Observational Cohort Study
202423 citationsauthor #4
Choroid plexus enlargement in acute neuroinflammation is tightly interrelated to the tyrosine receptor signalling
20241 citationsauthor #16
Re‐emergent Tremor in Parkinson's Disease: Evidence of Pathologic β and Prokinetic γ Activity
20245 citationsauthor #7
Inflammation‐Triggered Enlargement of Choroid Plexus in Subacute COVID‐19 Patients with Neurological Symptoms
202412 citationsauthor #9
Impact of Patient Input on the Study Execution of a Prospective, Epidemiological Study Assessing the Proportion of Stroke Survivors Who Develop Problematic Post-Stroke Spasticity
20240 citationsauthor #4
Dynamic reorganisation of the somatomotor network in multiple sclerosis - evidence from edge-centric functional connectivity analysis.
20241 citationsauthor #15
Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories
202428 citationsauthor #9
Disentangling neurodegeneration from ageing in multiple sclerosis: the brain-predicted disease duration gap
20240 citationsauthor #28
Concurrent inflammation-related brain reorganization in multiple sclerosis and depression.
20246 citationsauthor #19
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody‐associated Disease, Aquaporin‐4 Antibody‐Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis
202413 citationsauthor #30
Vagus nerve stimulation for the treatment of narcolepsy.
20248 citationsauthor #11
Children and Adolescent Patients with the Variants in the ATP1A3-encoded Sodium-Potassium ATPase Alpha-3 Subunit Demonstrate Impaired QT Response to Bradycardia and Predisposition to Sinus Node Dysfunction
20241 citationsauthor #30
Deep Learning Accelerated Brain Diffusion-Weighted MRI with Super Resolution Processing.
202413 citationsauthor #9
Subthalamic stimulation modulates context-dependent effects of beta bursts during fine motor control
20248 citationsauthor #11
Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
20246 citationsauthor #47
Cerebral vasculitis as a clinical manifestation of neurosarcoidosis: A scoping review.
20244 citationsauthor #2
Disentangling Neurodegeneration From Aging in Multiple Sclerosis Using Deep Learning
20249 citationsauthor #28
What was first and what is next in selecting device-aided therapy in Parkinson’s disease? Balancing evidence and experience
202411 citationsauthor #3
Low‐Frequency Deep Brain Stimulation in Non‐Rapid Eye Movement Sleep Modifies Memory Retention in Parkinson's Disease
20243 citationsauthor #5
Impact of deep Learning-enhanced contrast on diagnostic accuracy in stroke CT angiography.
20244 citationsauthor #7
Subthalamic control of impulsive actions: insights from deep brain stimulation in Parkinson’s disease
202414 citationsauthor #4
Cerebral vasculitis as clinical manifestation of neuroborreliosis: Pattern of vascular pathology and prognostic factors of outcome
20243 citationsauthor #15
Obsessive–compulsive symptoms and brain lesions compatible with multiple sclerosis
20244 citationsauthor #4
Ultrafast Brain MRI with Deep Learning Reconstruction for Suspected Acute Ischemic Stroke.
202430 citationsauthor #11
Altered cortical synaptic lipid signaling leads to intermediate phenotypes of mental disorders
20245 citationsauthor #27
The importance of epidemiological data in motor neurophysiology.
20231 citationsauthor #2
Translating Pathological Brain Activity Primers in Parkinson’s Disease Research
20237 citationsauthor #5
Inhibitory and excitatory responses in the dorso-medial prefrontal cortex during threat processing
20232 citationsauthor #8
Pitolisant-supported bridging during drug holidays to deal with tolerance to modafinil in patients with narcolepsy.
20234 citationsauthor #7
Ultrafast Brain MRI Protocol at 1.5 T Using Deep Learning and Multi-shot EPI.
202315 citationsauthor #8
Eslicarbazepine acetate for the treatment of status epilepticus.
20234 citationsauthor #4
Third-Generation Antiseizure Medication in the Treatment of Benzodiazepine-Refractory Status Epilepticus in Poststroke Epilepsy: A Retrospective Observational Register-Based Study
20232 citationsauthor #6
Clinical neurophysiological interrogation of motor slowing: A critical step towards tuning adaptive deep brain stimulation
202314 citationsauthor #11
FIFA Initiatives Improved Survival After Loss of Consciousness During Football Games
20230 citationsauthor #4
Re-emergent Tremor during stable posture in Parkinson's Disease: Evidence of Pathological Beta and Prokinetic Gamma Activity
20230 citationsauthor #6
Prognostic value of single-subject grey matter networks in early multiple sclerosis
202315 citationsauthor #23
Favorable combinations of antiseizure medication with vagus nerve stimulation to improve health-related quality of life in patients with epilepsy.
20234 citationsauthor #7
The role of ipsilateral motor network in upper limb movement
202310 citationsauthor #8
ID: 221102 An Interim Report on Real-World Outcomes for Parkinson's Disease and Disabling Tremor Subjects in ADROIT
20230 citationsauthor #1
Perspectives of Implementation of Closed-Loop Deep Brain Stimulation: From Neurological to Psychiatric Disorders
202317 citationsauthor #1
Modifying the progression of Parkinson's disease through movement interventions: multimodal quantification of underlying mechanisms
20231 citationsauthor #5
Diffusion-based structural connectivity patterns of multiple sclerosis phenotypes
20239 citationsauthor #14
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study
202314 citationsauthor #14
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
2023162 citationsauthor #47
Focal Cortex Stimulation With a Novel Implantable Device and Antiseizure Outcomes in 2 Prospective Multicenter Single-Arm Trials
202336 citationsauthor #12
Clinical neurophysiological interrogation of motor slowing: A critical step towards tuning adaptive deep brain stimulation
20230 citationsauthor #12
Using The Virtual Brain to study the relationship between structural and functional connectivity in patients with multiple sclerosis: a multicenter study.
202310 citationsauthor #6
Clinical feasibility and validation of the accelerated T2 mapping sequence GRAPPATINI in brain imaging.
20235 citationsauthor #6
Dynamic modulation of subthalamic nucleus activity facilitates adaptive behavior
20239 citationsauthor #10
Synergistic effects of vagus nerve stimulation and antiseizure medication
202311 citationsauthor #12
Correction to: Synergistic effects of vagus nerve stimulation and antiseizure medication
20231 citationsauthor #12
Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort
20233 citationsauthor #18
Identification of multiple sclerosis endophenotypes by high dimensional blood signatures associated with distinct disease trajectories (P1-3.008)
20230 citationsauthor #14
The excitability of ipsilateral motor evoked potentials is not task-specific and spatially distinct from the contralateral motor hotspot
20224 citationsauthor #5
Gait Abnormalities in Parkinson’s Disease Are Associated with Extracellular Free-Water Characteristics in the Substantia Nigra
20229 citationsauthor #9
Serum Neurofilament Identifies Patients With Multiple Sclerosis With Severe Focal Axonal Damage in a 6-Year Longitudinal Cohort
202214 citationsauthor #8
Early spinal cord pseudoatrophy in interferon‐beta‐treated multiple sclerosis
20221 citationsauthor #8
Reduced Cross-Frequency Coupling and Daytime Sleepiness in Obstructive Sleep Apnea Patients
20229 citationsauthor #8
EEG-Based Mapping of Resting-State Functional Brain Networks in Patients with Parkinson’s Disease
202214 citationsauthor #5
Brain network correlates of epilepsy occurrence in multiple sclerosis and neuroinflammation
20225 citationsauthor #6
Deciphering the Network Effects of Deep Brain Stimulation in Parkinson's Disease
202212 citationsauthor #9
Treadmill training in Parkinson’s disease is underpinned by the interregional connectivity in cortical-subcortical network
202212 citationsauthor #9
Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy, and Traumatic Brain Injury
202231 citationsauthor #6
Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis
202214 citationsauthor #10
Benefits and Risks of a Staged‐Bilateral VIM Versus Unilateral VIM DBS for Essential Tremor
202213 citationsauthor #8
Association of obesity with disease outcome in multiple sclerosis
202273 citationsauthor #12
Efficacy and safety of antiseizure medication in post-stroke epilepsy.
202222 citationsauthor #6
Machine learning aided classification of tremor in multiple sclerosis
202210 citationsauthor #9

TIMELINE

2007 168 citations

2011 82 citations

2012 4 citations

2013 0 citations

2015 42 citations

2016 280 citations

2017 966 citations

2018 442 citations

2019 581 citations

2020 886 citations

2021 557 citations

2022 520 citations

2023 356 citations

2024 213 citations

2025 55 citations

2026 0 citations

Unknown 13 citations

Sergiu Groppa

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT